To study the difference of serum Vitamin D3 level and calcium profile in childhood multitransfused beta-thalassemia major between children receiving chelation therapy and those not receiving chelation therapy in a tertiary care hospital, Kolkata
DOI:
https://doi.org/10.71152/ajms.v16i5.4459Keywords:
Multi-transfused; Beta-thalassemia; Vitamin D3; Calcium profile; Children; Chelation therapyAbstract
Background: Most cases of beta-thalassemia major in children are associated with potentially severe clinical characteristics such as poor growth, feeding difficulties, hepatosplenomegaly, bone metabolic disorders, and skeletal abnormalities.
Aims and Objectives: In our study, we evaluated the demographic and clinical presentations with the serum ferritin level, serum calcium, serum Vitamin D3 level, and serum phosphate level of 85 patients who received blood transfusions at regular intervals.
Materials and Methods: We recruited children with beta-thalassemia major, confirmed by hemoglobin electrophoresis, for this study. We recorded the demographic details and blood transfusion status. We estimated serum ferritin, serum Vitamin D3 level, serum calcium, and serum PO4 using Enzyme-linked immunosorbent assay.
Results: Of the 85 patients, 71 started chelation and 14 refused. 72 were non-consanguineous, and 13 were consanguineous offspring. 66% of the total patients had ferritin levels exceeding 1000 ng/mL. Marriage types did not show a significant association with ferritin. After 20 infusions, coagulation began at 83.53%. A significant link exists between chelation therapy and total transfusions. Nearly 40% of children (47.06%) had calcium levels <8 mg/dL. 23 (27.06%) of the 85 patients exhibited hypophosphatemia.
Conclusion: In most people, chemotherapy does not impact their serum PO4 levels. We have found a significant association between frequent red cell transfusions during chelation therapy and increased levels of ferritin, Vitamin D3, calcium, and phosphate.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
